| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/02/2001 | US20010010822 For pharmaceutical preparations |
| 08/02/2001 | US20010010820 Delaying onset of insulin dependent diabetes mellitus by administering immunologically active monoclonal antibody against glutamic acid decarboxylase coupled to a nonimmunogenic polymer that provides shell around antibody |
| 08/02/2001 | US20010010818 Methods and formulations for reducing circulating antibodies |
| 08/02/2001 | US20010010811 Contrast agents |
| 08/02/2001 | DE10038108A1 Pharmazeutische Zusammensetzungen Pharmaceutical compositions |
| 08/02/2001 | DE10003757A1 Ibuprofen-Wirkstoffzubereitung Ibuprofen drug preparation |
| 08/02/2001 | DE10003620A1 Non-aqueous solution or suspension of 5-aminolevulinic acid, is useful in the treatment or diagnosis of tumor diseases or psoriasis by photodynamic therapy |
| 08/02/2001 | CA2399229A1 Surfactant free topical compositions and method for rapid preparation thereof |
| 08/02/2001 | CA2398788A1 Slow release protein polymers |
| 08/02/2001 | CA2398723A1 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 08/02/2001 | CA2398642A1 Mucin synthesis inhibitors |
| 08/02/2001 | CA2398611A1 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 08/02/2001 | CA2398533A1 Compressed microparticles for dry injection |
| 08/02/2001 | CA2398288A1 Ibuprofen containing active agent preparation |
| 08/02/2001 | CA2398284A1 Methods and compositions for generating human monoclonal antibodies |
| 08/02/2001 | CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | CA2396884A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | CA2396711A1 Composition for intestinal delivery |
| 08/02/2001 | CA2396640A1 Electrospun pharmaceutical compositions |
| 08/02/2001 | CA2396628A1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
| 08/02/2001 | CA2395447A1 Palatable arginine compounds and uses thereof for cardiovascular health |
| 08/02/2001 | CA2395446A1 Compositions, kits, and methods for cardiovascular health |
| 08/02/2001 | CA2383626A1 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes |
| 08/01/2001 | EP1120439A1 Injectable ceramic compositions and methods for their preparation and use |
| 08/01/2001 | EP1120427A1 Method for the formation of low-substituted hydroxypropyl cellulose particles |
| 08/01/2001 | EP1120116A1 Antimycotic drug composition |
| 08/01/2001 | EP1120112A2 Wound dressing and drug delivery device |
| 08/01/2001 | EP1120109A2 Rapidly disintegrating and fast dissolving solid dosage form |
| 08/01/2001 | EP1120107A1 Nutritional supplement based on blackcurrant seed oil |
| 08/01/2001 | EP1120101A2 Nanoemulsion containing amphiphilc lipids and a PEG ester and its use in cosmetics |
| 08/01/2001 | EP1119630A1 Nucleic acid constructs for genetic immunisation |
| 08/01/2001 | EP1119379A1 Drug delivery device for stent |
| 08/01/2001 | EP1119374A2 Polyurethanes as topical skin protectants |
| 08/01/2001 | EP1119373A1 Oxybutynin formulations and methods of use |
| 08/01/2001 | EP1119371A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 08/01/2001 | EP1119360A1 Methods and compositions for increasing intestinal absorption of fats |
| 08/01/2001 | EP1119350A2 Rar antagonists as male anti-fertility agents |
| 08/01/2001 | EP1119347A1 Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
| 08/01/2001 | EP1119345A1 Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles |
| 08/01/2001 | EP1119335A1 Capsules |
| 08/01/2001 | EP1119334A1 Two chamber cartridge for atomizers |
| 08/01/2001 | EP1119315A2 Delivery of phosphoinositide polyphosphates into cells |
| 08/01/2001 | EP0957938B1 Composition with base of coconut oil and its use |
| 08/01/2001 | EP0952823B1 Stabilized pharmaceutical compositions and process for the preparation thereof |
| 08/01/2001 | EP0820308B1 Conjugate for treating inflammatory diseases |
| 08/01/2001 | EP0748218B1 Plaster-shaped transdermal system with a tamoxifen derivative |
| 08/01/2001 | EP0569583B1 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 08/01/2001 | CN1306572A Soluble T cell receptor |
| 08/01/2001 | CN1306444A Medical device having anti-infective and contraceptive properties |
| 08/01/2001 | CN1306440A Inhibiting undesirable taste in oral compsns |
| 08/01/2001 | CN1306438A Adjuvant compsn. and methods for its use |
| 08/01/2001 | CN1306421A Matrix-type transdermal patch for steroid homones |
| 08/01/2001 | CN1306420A Methods for treating capules and dry powdered pharmaceutical formulations |
| 08/01/2001 | CN1306007A Dry cell factor |
| 08/01/2001 | CN1305805A Compsns. contg. ascorbic acid and pectin |
| 08/01/2001 | CN1305791A Stretchable hood utensil contg. stretchable adhesive matrix at least in moisture state |
| 07/31/2001 | US6268524 Method for preparation of disodium pamidronate |
| 07/31/2001 | US6268411 Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 07/31/2001 | US6268390 Inhibiting stenosis following vascular trauma or disease in a mammalian host. |
| 07/31/2001 | US6268385 Dry blend pharmaceutical formulations |
| 07/31/2001 | US6268368 Antidepressants |
| 07/31/2001 | US6268356 Flocculated suspension of megestrol acetate |
| 07/31/2001 | US6268355 Stable aspirin-containing preparations for external use |
| 07/31/2001 | US6268335 Insoluble insulin compositions |
| 07/31/2001 | US6268159 Visualizing tumor cells; administer radioactive particles to humans and detect positioning and accumulation of radioactive particles in body |
| 07/31/2001 | US6268053 Blend of macromolecule and polymer |
| 07/31/2001 | US6267990 Preparation comprising initial dose of ace inhibitor optionally including excipient, first delayed-release pellet, in which active ingredient and optional excipient are covered with coating, second coated delayed-release pellet |
| 07/31/2001 | US6267987 Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake |
| 07/31/2001 | US6267985 Clear oil-containing pharmaceutical compositions |
| 07/31/2001 | US6267984 Improved transdermal drug delivery |
| 07/31/2001 | US6267968 MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same |
| 07/31/2001 | US6267964 Administering conjugate containing biologically active protein or peptide and polypeptide of bacterial origin that binds to serum albumin protein of mammalian origin; conjugate exhibiting enhanced in vivo half-life |
| 07/31/2001 | US6267957 Attaching agents to tissue with transglutaminase and a transglutaminase substrate |
| 07/31/2001 | US6267808 Mixture of dextrose, film forming, sodium citrate and titanium dioxide |
| 07/31/2001 | CA2107553C Monoclonal antibodies to stem cell factor receptors |
| 07/31/2001 | CA2068763C Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| 07/31/2001 | CA2041989C Aqueous pharmaceutical formulations of erythropoietin and the use thereof |
| 07/31/2001 | CA1341276C Hyaluronic acid esters and salts |
| 07/26/2001 | WO2001053463A2 COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES |
| 07/26/2001 | WO2001053444A1 Antimicrobial compositions |
| 07/26/2001 | WO2001053355A1 An in vivo screen using chemical inducers of dimerization |
| 07/26/2001 | WO2001053354A2 Methods for treating tumors using a fusion protein comprising il-2- polypeptides and p185-specific binding molecules |
| 07/26/2001 | WO2001053344A2 Chondromodulin-i related peptide |
| 07/26/2001 | WO2001053342A1 Chimeric prostate-homing peptides with pro-apoptotic activity |
| 07/26/2001 | WO2001053336A1 Clostridial toxin derivatives and methods for treating pain |
| 07/26/2001 | WO2001053324A2 Novel haptotactic peptides |
| 07/26/2001 | WO2001052937A1 Mixed buffer system for stabilizing polypeptide formulations |
| 07/26/2001 | WO2001052903A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | WO2001052901A1 Drugs for gene therapy |
| 07/26/2001 | WO2001052900A2 Novel orthogonally protected amino acid chelators for biomedical applications |
| 07/26/2001 | WO2001052899A1 Chelating agents and method for their use as tandem metal chelators and hydrophilic spacers for medical diagnosis and therapy |
| 07/26/2001 | WO2001052898A1 Methods for incorporating metal chelators at carboxyl-terminal site of peptides |
| 07/26/2001 | WO2001052897A2 Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitors |
| 07/26/2001 | WO2001052896A2 Compositions with enhanced oral bioavailability |
| 07/26/2001 | WO2001052895A1 Pharmaceutical compositions comprising terbinafine |
| 07/26/2001 | WO2001052894A2 Nasally administrable cyclic peptide compositions |
| 07/26/2001 | WO2001052893A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | WO2001052889A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 07/26/2001 | WO2001052888A2 Improved dna vaccines for production-type animals |
| 07/26/2001 | WO2001052884A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |